FDAnews Drug Daily Bulletin

GLAXOSMITHKLINE REACHES AGREEMENT TO UPDATE PRODUCT LABEL

April 10, 2006
A A

New York: Pharmaceutical giant GlaxoSmithKline has reached an agreement to update its product label for its popular drug Advair with a new warning that advises doctors to limit its use only to patients who are not controlled on other asthma drugs.
New Kerala